Geoffrey McDonough

Mimecast Outlook Greenhouse.io Adobe Marketing Cloud Typekit Akamai RUM Mobile Friendly Nginx WordPress.org reCAPTCHA Remote

biotechnology lnps sirna autoimmune disease t cells biotechnology: pharmaceutical preparations health care biotechnology research genetic medicine non-viral gene therapy ctlnp delivery iqdna platform redosable therapy cell-targeted lipid nanoparticle immune-quiet dna hemophilia treatment sickle cell disease t cell therapies hematopoietic stem cells durable gene expression in vivo genetic modification scalable manufacturing rna delivery system strategic partnerships therapeutic proteins clinical trials germline gene editing vector optimization genetic disorders gene editing technologies multiplexed gene corrections low-cost therapeutics broad therapeutic reach modular delivery system patient-centric approach cell reprogramming biologic treatments intravenous gene therapy targeting ligands broad access to treatment high capacity dna constructs enhanced efficacy therapies rare disease treatment disease correction quick manufacturing processes research & development efficiency global health solutions community engagement personalized medicine translational science cell-free processes therapeutic innovations biopharmaceutical development genetic therapeutic reach innovative delivery methods pharmaceutical manufacturing genetic medicines t cell-driven autoimmune diseases cell-targeted lipid nanoparticles sirna therapeutics gene modulation selective targeting redosable pharmacology genetic precision therapeutic development rare genetic disorders prevalent diseases biopharmaceutical collaborations healthcare providers rna interference immunology innovative therapies patient-centric solutions advanced genetic technologies unmet medical needs durable treatments gene therapy precision medicine therapeutic index safety profile tissue damage reduction inflammation modulation health wellness & fitness hospital & health care pharmaceuticals medical